NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/12/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization35.01 mln
Float1.67 mln
Earnings Date08/18/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
41.94
Highly suspicious
1-Year Forecast
36.00
Transformational upside
Relative Strength
8
/ 100
Severely lagging
Debt / Equity
0.43
Low leverage
ROE
-47.26
Deeply negative
Business Description
PAVmed is a US-based medical company focused on bringing new healthcare solutions to patients with underserved medical needs. Its current offerings include CarpX, a minimally invasive device for treating carpal tunnel syndrome, and EsoCheck and EsoGuard, which work together to detect early signs of esophageal cancer in patients with chronic acid reflux. The company is also developing additional tools for cancer treatment and vascular access. Founded in 2014 and based in New York, PAVmed continues to grow its portfolio of innovative medical technologies.
